Full Name
Yan Yee Mark Chan
Variants
Chan, M.Y.
Chan, M.Y.Y.
Chan, M.
Chan, Mark
Chan, Yan Yee Mark
Chan, Yan Yee Mark
 
Main Affiliation
 
 
Email
mdccyym@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 2023]
Date Issued:  [2010 TO 2019]

Results 1-20 of 53 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
11-Oct-20192348Novel direct thrombin inhibitor achieves superior antithrombotic effect with lower bleeding risk than heparin or bivalirudinKoh, CY; Shih, N; Leong, EJE; Amran, FS; Li, AWL; Kini, RM; Chan, M.Y. 
22011A new model of delirium care in the acute geriatric setting: Geriatric monitoring unitChong, M; Chan, M.P.C ; Kang, J ; Han, H; Ding, Y ; Tan, T
31-Apr-2018A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world populationZhao, Ying Jiao; Teng, Monica; Khoo, Ai Leng; Ananthakrishna, Rajiv; Yeo, Tiong Cheng ; Lim, Boon Peng; Loh, Joshua P ; Chan, Mark Y 
42015Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-examination study (Bioresorbable Vascular Scaffold-a clinicalBrugaletta, S.; Gori, T.; Low, A.F. ; Tousek, P.; Pinar, E.; Gomez-Lara, J.; Scalone, G.; Schulz, E.; Chan, M.Y. ; Kocka, V.; Hurtado, J.; Gomez-Hospital, J.A.; Munzel, T.; Lee, C.-H. ; Cequier, A.; Valdes, M.; Widimsky, P.; Serruys, P.W
52015Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).LOW, F ; CHAN, Y ; LEE, C 
61-Jul-2016ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparisonBrugaletta, Salvatore; Gori, Tommaso; Low, Fatt Hoe Adrian ; Tousek, Petr; Pinar, Eduardo; Gomez-Lara, Josep; Ortega-Paz, Luis; Schulz, Eberhard; Chan, M.Y. ; Kocka, Viktor; Hurtado, Jose; Antoni Gomez-Hospital, Joan; Giacchi, Giuseppe; Muenzel, Thomas; Lee, Chi-Hang ; Cequier, Angel; Valdes, Mariano; Widimsky, Petr; Serruys, Patrick W; Sabate, Manel
71-Jan-2016Acute coronary syndrome in the Asia-Pacific regionChan, Mark Y ; Du, Xin; Eccleston, David; Ma, Changsheng; Mohanan, Padinhare P; Ogita, Manabu; Shyu, Kou-Gi; Yan, Bryan P; Jeong, Young-Hoon
82013AHA 2012: The 85th Scientific Sessions of American Heart AssociationPatel, M.R.; Van Diepen, S.; Halperin, J.L.; Piccini, J.P.; Chan, M.Y. ; Mantovani, L.; Gibson, C.M.; Mega, J.L.
915-Jan-2019Air pollution in relation to very short-term risk of ST-segment elevation myocardial infarction: Case-crossover analysis of SWEDEHEARTSahlen, Anders ; Ljungman, Petter; Erlinge, David; Chan, Mark Y ; Yap, Jonathan ; Hausenloy, Derek J ; Yeo, Khung Keong ; Jernberg, Tomas
10Dec-2013Anticoagulation and monitoring of a novel and reversible factor IXa inhibitorBecker, R.C.; Chan, M.Y. ; Vavalle, J.P.; Povsic, T.J.
111-Oct-2019Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndromeKwee, Lydia Coulter; Neely, Megan L; Grass, Elizabeth; Gregory, Simon G; Roe, Matthew T; Ohman, E Magnus; Fox, Keith AA; White, Harvey D; Armstrong, Paul W; Bowsman, Lenden M; Haas, Joseph; Duffin, Kevin L; Chan, Mark Y ; Shah, Svati H
121-Jul-2017Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatumIyer, Janaki Krishnamoorthy; Koh, Cho Yeow ; Kazimirova, Maria; Roller, Ladislav; Jobichen, Chacko; Swaminathan, Kunchithapadam ; Mizuguchi, Jun; Iwanaga, Sadaaki; Nuttall, Patricia A; Chan, Mark Y ; Kini, R Manjunatha 
131-Feb-2019Cardiac motion and spillover correction for quantitative PET imaging using dynamic MRIMarchesseau, Stephanie ; Totman, John J; Fadil, Hakim ; Leek, Francesca AA; Chaal, Jasper ; Richards, Mark ; Chan, Mark ; Reilhac, Anthonin 
141-Jul-2019Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarctionLeow, Aloysius Sheng-Ting; Sia, Ching-Hui ; Tan, Benjamin Yong-Qiang; Kaur, Rajinderdeep; Yeo, Tiong-Cheng ; Chan, Mark Yan-Yee ; Tay, Edgar Lik-Wui; Seet, Raymond Chee-Seong; Loh, Joshua Ping-Yun; Yeo, Leonard Leong-Litt
152015Circadian dependence of infarct size and acute heart failure in ST elevation myocardial infarctionSeneviratna A.; Lim G.H.; Devi A.; Carvalho L.P.; Chua T.; Koh T.-H.; Tan H.-C.; Foo D.; Tong K.-L.; Ong H.-Y.; Richards A.M. ; Yew C.K.; Chan M.Y. 
161-Sep-2019Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionSim, HW; Thong, EH; Tan, HC ; Low, AF ; Lee, CH; Chan, MY ; Tay, EL ; Loh, PH ; Chan, KH ; Loh, JP 
17Feb-2012Clopidogrel pharmacogenetics of east, south and other Asian populationsChan, M.Y. 
181-Aug-2016Comparison of Long-Term Mortality of Patients Aged >= 40 Versus > 40 Years With Acute Myocardial InfarctionJing, Mingxue; Gao, Fei ; Chen, Qifeng; de Carvalho, Leonardo P ; Sim, Ling-Ling; Koh, Tian-Hai ; Foo, David ; Ong, Hean-Yee ; Tong, Khim-Leng ; Tan, Huay-Cheem ; Yeo, Tiong-Cheng ; Roe, Matthew T; Chua, Terrance ; Chan, Mark Y 
191-May-2016Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary SyndromeZhao, YJ; Khoo, AL; Lin, L; Teng, M; Wu, TS; Chan, M.Y. ; Lim, BP
201-May-2017Development of bioanalytical assays for variegin, a peptide-based bivalent direct thrombin inhibitorShih, Norrapat; de Carvalho, Leonardo Pinto; Lee, Yie Hou; Rocha, Mauricio Macario; Pereira Barbosa, Adriano Henrique; de Sousa, Jose Marconi A; Carvalho, Antonio Carlos de C; Kini, R Manjunatha ; Chan, Mark Y